Manitoba Diabetes Advocacy, GLP-1 Drug Access, and Caregiver Crisis
Update: 2025-12-03
Description
In this episode, Dr. Chi-Ming Chow discusses diabetes advocacy efforts and the government response in Manitoba schools, highlighting the importance of support for students with diabetes. He examines the issues surrounding GLP-1 drugs in relation to WHO obesity guidelines and concerns over accessibility. An FDA alert regarding faulty glucose monitors is addressed, emphasizing the need for vigilance among users. The episode explores the caregiver crisis affecting healthcare and its implications for the system. Dr. Chow also delves into the challenges of polypharmacy and supplement use in psychiatric care, providing insights into managing complex medication regimens.
(0:00 ) Welcome and introduction
(0:21 ) Diabetes advocacy and government response in Manitoba schools
(3:13 ) GLP-1 drugs, WHO obesity guidelines, and accessibility concerns
(6:08 ) FDA alert on faulty glucose monitors
(8:33 ) Caregiver crisis in healthcare
(12:59 ) Polypharmacy and supplement use in psychiatric care
(0:00 ) Welcome and introduction
(0:21 ) Diabetes advocacy and government response in Manitoba schools
(3:13 ) GLP-1 drugs, WHO obesity guidelines, and accessibility concerns
(6:08 ) FDA alert on faulty glucose monitors
(8:33 ) Caregiver crisis in healthcare
(12:59 ) Polypharmacy and supplement use in psychiatric care
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
